MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
Open Access
- 31 August 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (17) , 4697-4709
Abstract
Evolution of tumor cell phenotypes promotes heterogeneity and therapy resistance. Here we found that induction of CD73, the enzyme that generates immunosuppressive adenosine, is linked to melanoma phenotype switching. Activating MAPK mutations and growth factors drove CD73 expression, which marked both nascent and full activation of a mesenchymal-like melanoma cell state program. Proinflammatory cytokines like TNFα cooperated with MAPK signaling through the c-Jun/AP-1 transcription factor complex to activate CD73 transcription by binding to an intronic enhancer. In a mouse model of T-cell immunotherapy, CD73 was induced in relapse melanomas, which acquired a mesenchymal-like phenotype. We also detected CD73 upregulation in melanoma patients progressing under adoptive T-cell transfer or immune checkpoint blockade, arguing for an adaptive resistance mechanism. Our work substantiates CD73 as a target to combine with current immunotherapies, but its dynamic regulation suggests limited value of CD73 pretreatment expression as a biomarker to stratify melanoma patients. Cancer Res; 77(17); 4697–709. ©2017 AACR.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical PerspectiveCancer Discovery, 2013
- T-helper-1-cell cytokines drive cancer into senescenceNature, 2013
- A Landscape of Driver Mutations in MelanomaCell, 2012
- CD73: a potent suppressor of antitumor immune responsesTrends in Immunology, 2012
- NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificityBritish Journal of Cancer, 2012
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Modeling Genomic Diversity and Tumor Dependency in Malignant MelanomaCancer Research, 2008
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive StatesCancer Research, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Wnt5a signaling directly affects cell motility and invasion of metastatic melanomaCancer Cell, 2002